Mylan Pharmaceuticals Inc. will have to face antitrust claims that it conspired with other drugmakers to inflate generic drug ...

Of the total proceeds via the share sale, up to Rs 3,620 crore will be utilised mainly towards payment to Mylan Inc. (Viatris ...

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings ...

According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...

Lara Ramsburg, a 25-year veteran at Mylan and Viatris, will lead human resources and corporate affairs at the Canonsburg ...

Notre Dame has received a commitment from former Purdue Boilermakers kicker Spencer Porath this evening filling the final ...

(B) The report delivers a comprehensive analysis of global, regional, and country-level Mesalamine market revenues, extending projections until 2030. This dataset empowers companies to gauge their ...

The global cyanocobalamin market size was US$ 167.7 billion in 2021. The global cyanocobalamin market is forecast to grow to US$ 250.1 billion by 2030, registering a compound annual growth rate (CAGR) ...

The global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.75% between 2025 and ...

Bengaluru: Biocon Limited on Monday said its wholly owned subsidiary, Biocon Pharma Limited, has received approval from the ...